Ceritinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Ceritinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have a certain type of abnormal anaplastic lymphoma kinase (ALK) gene. Your doctor will test for the presence of this gene. Ceritinib is an antineoplastic (cancer) agent.Ceritinib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceritinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)-N-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)nitrous amide. Synchemia is the leading manufacturing and exporter of Ceritinib Nitroso Impurity 2 . We supply Ceritinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014967 |
| CAS No | NA |
| Mol.F. | C15H19N3O4S |
| Mol.Wt. | 337.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014968 |
| CAS No | NA |
| Mol.F. | C16H17N3O5S |
| Mol.Wt. | 363.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014969 |
| CAS No | 614-01-7 |
| Mol.F. | 137.1 |
| Mol.Wt. | C6H7N3O |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014970 |
| CAS No | NA |
| Mol.F. | C7H9N5O4 |
| Mol.Wt. | 227.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014971 |
| CAS No | 343853-74-7 |
| Mol.F. | C6H7N3O3S |
| Mol.Wt. | 201.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014972 |
| CAS No | NA |
| Mol.F. | C6H8N4O3S |
| Mol.Wt. | 216.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014973 |
| CAS No | NA |
| Mol.F. | C9H9N5O |
| Mol.Wt. | 203.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014974 |
| CAS No | NA |
| Mol.F. | C15H18N6O |
| Mol.Wt. | 298.4 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014975 |
| CAS No | NA |
| Mol.F. | C15H18ClN5O3S |
| Mol.Wt. | 383.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014976 |
| CAS No | NA |
| Mol.F. | C33H46N9O5S |
| Mol.Wt. | 680.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014977 |
| CAS No | NA |
| Mol.F. | C614CH16N2O6 |
| Mol.Wt. | 226.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014978 |
| CAS No | NA |
| Mol.F. | C17H24N4O3 |
| Mol.Wt. | 332.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014979 |
| CAS No | NA |
| Mol.F. | C24H25N3O5 |
| Mol.Wt. | 435.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014980 |
| CAS No | NA |
| Mol.F. | C24H24N4O6 |
| Mol.Wt. | 464.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014981 |
| CAS No | NA |
| Mol.F. | C52H87N11O16 |
| Mol.Wt. | 1122.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014982 |
| CAS No | 2788-23-0 |
| Mol.F. | C12H8N2O |
| Mol.Wt. | 196.2 |
| INV STATUS | In Stock |